GALENA BIOPHARMA, INC.
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2003-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://galenabiopharma.com
A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders
- Conditions
- Interventions
- First Posted Date
- 2014-04-29
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- Galena Biopharma, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT02125318
- Locations
- 🇺🇸
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸East Valley Hematology and Oncology Medical Group, Burbank, California, United States
🇺🇸California Cancer Associates for Research & Excellence (cCARE), Escondido, California, United States
Observational Registry Study of Quality of Life When Treating BTcP With Abstral
- First Posted Date
- 2013-09-06
- Last Posted Date
- 2015-11-05
- Lead Sponsor
- Galena Biopharma, Inc.
- Target Recruit Count
- 164
- Registration Number
- NCT01936636
- Locations
- 🇺🇸
Florida Cancer Care, Plantation, Florida, United States
🇺🇸Coastal Pain Research, Carlsbad, California, United States
🇺🇸Navajo Road Pain Management Center, El Cajon, California, United States
Efficacy and Safety Study of NeuVaxâ„¢ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
- Conditions
- Interventions
- First Posted Date
- 2011-11-24
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- Galena Biopharma, Inc.
- Target Recruit Count
- 758
- Registration Number
- NCT01479244
- Locations
- 🇨🇿
University Hospital Hradec Kralove, Clinic of Oncology and Radiotherapy, Hradec Kralove, Czech Republic
ðŸ‡ðŸ‡ºBorsod-Abauj-Zemplen County Hospital and University Educational Hospital, Center for Clinical Oncology and Radiology, Miskolc, Hungary
🇷🇺Nizhny Novgorod Regional Oncology Center, Nizhny Novgorod, Russian Federation